| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 133.49B | 141.87B | 137.95B | 141.32B | 104.10B | 88.92B |
| Gross Profit | 25.02B | 28.52B | 29.28B | 28.73B | 14.95B | 13.33B |
| EBITDA | 24.72B | 35.35B | 35.63B | 37.69B | 25.82B | 20.50B |
| Net Income | 14.89B | 18.37B | 19.75B | 22.68B | 12.53B | 7.66B |
Balance Sheet | ||||||
| Total Assets | 300.80B | 306.43B | 293.23B | 265.45B | 247.13B | 245.61B |
| Cash, Cash Equivalents and Short-Term Investments | 13.45B | 11.63B | 17.88B | 14.54B | 11.66B | 13.30B |
| Total Debt | 122.07B | 122.65B | 123.70B | 116.53B | 125.90B | 136.90B |
| Total Liabilities | 157.38B | 160.79B | 161.10B | 154.87B | 155.80B | 165.78B |
| Stockholders Equity | 143.31B | 145.50B | 132.07B | 110.56B | 91.31B | 79.73B |
Cash Flow | ||||||
| Free Cash Flow | 5.07B | -3.83B | 17.43B | 13.60B | 3.28B | -11.59B |
| Operating Cash Flow | 8.55B | 30.73B | 29.45B | 35.27B | 15.78B | 19.28B |
| Investing Cash Flow | -2.54B | -30.79B | -22.01B | -18.49B | -3.12B | -22.99B |
| Financing Cash Flow | -6.88B | -8.32B | -3.87B | -13.25B | -14.82B | 2.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥1.56T | 10.15 | 11.32% | 5.12% | -3.92% | -58.37% | |
79 Outperform | ¥184.99B | 7.23 | 13.08% | 3.75% | -7.12% | 29.40% | |
77 Outperform | ¥2.27T | 11.76 | 10.82% | 6.25% | -5.87% | -48.33% | |
76 Outperform | ¥171.93B | 7.21 | ― | 4.08% | -10.56% | -10.56% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥12.37B | 1,812.20 | ― | 5.77% | 8.37% | -87.14% | |
55 Neutral | ¥2.14T | 17.02 | 10.90% | 5.81% | 2.80% | -47.61% |